Literature DB >> 33561945

Trends of Testicular Cancer Mortality-to-Incidence Ratios in Relation to Health Expenditure: An Ecological Study of 54 Countries.

Shao-Chuan Wang1,2,3, Nai-Wen Chang1, Wen-Jung Chen1,2,3, Min-Hsin Yang1,3, Sung-Lang Chen1,2,3, Wen-Wei Sung1,2,3.   

Abstract

Favorable testicular cancer mortality-to-incidence ratios (MIRs) are associated with health care disparities, including health care expenditures, but the trends of testicular MIR and health care disparity remain unclear. We evaluated changes in MIR as the difference between 2012 and 2018, termed delta MIRMIR). Health care expenditures and the human development index (HDI) were obtained from the World Health Organization and the Human Development Report Office of the United Nations Development Programme. The association between the variables was analyzed by Spearman's rank correlation coefficient. A total of 54 countries were included in the criteria of data quality reports and missing data. By continent, the most favorable MIR was in Oceania (0.03) while it was 0.36 in Africa. In these areas, the incidence rates were positively correlated to health care expenditure, but the mortality rates showed a reversed correlation. The MIR ranged from 0.01 to 0.34 and the δMIR ranged from -0.05 to 0.34. The favorable MIRs are correlated to high health care expenditure and HDI (all p < 0.001). Interestingly, favorable δMIRs tend to be seen in countries with relatively low health care expenditure and HDI (all p < 0.001). In conclusion, favorable testicular cancer MIRs are associated with high HDI and health care expenditure, but the improvement in MIR between 2012 and 2018 (δMIR) is negatively correlated with HDI and health care expenditure.

Entities:  

Keywords:  health expenditures; incidence; mortality; testicular neoplasms

Year:  2021        PMID: 33561945      PMCID: PMC7914754          DOI: 10.3390/ijerph18041546

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  29 in total

1.  Incidence and Mortality of Testicular Cancer and Relationships with Development in Asia.

Authors:  Mostafa Sadeghi; Mahshid Ghoncheh; Abdollah Mohammadian-Hafshejani; Hamidreza Sadeghi Gandomani; Hosein Rafiemanesh; Hamid Salehiniya
Journal:  Asian Pac J Cancer Prev       Date:  2016

2.  Perspectives on a Global Change in Testicular Cancer Incidence.

Authors:  Mikkel Fode; Christian Fuglesang Jensen; Nessn Azawi; Peter Buch Østergren
Journal:  Eur Urol       Date:  2019-08-04       Impact factor: 20.096

3.  Global, regional and national burden of testicular cancer, 1990-2016: results from the Global Burden of Disease Study 2016.

Authors:  Farhad Pishgar; Arvin Haj-Mirzaian; Hedyeh Ebrahimi; Sahar Saeedi Moghaddam; Bahram Mohajer; Mohammad Reza Nowroozi; Mohsen Ayati; Farshad Farzadfar; Christina Fitzmaurice; Erfan Amini
Journal:  BJU Int       Date:  2019-05-03       Impact factor: 5.588

4.  The colorectal cancer mortality-to-incidence ratio as an indicator of global cancer screening and care.

Authors:  Vasu Sunkara; James R Hébert
Journal:  Cancer       Date:  2015-01-08       Impact factor: 6.860

5.  Testicular cancer mortality in the Americas, 1980-2003.

Authors:  Paola Bertuccio; Matteo Malvezzi; Liliane Chatenoud; Cristina Bosetti; Eva Negri; Fabio Levi; Carlo La Vecchia
Journal:  Cancer       Date:  2007-02-15       Impact factor: 6.860

6.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

7.  Testicular cancer incidence predictions in Europe 2010-2035: A rising burden despite population ageing.

Authors:  Ariana Znaor; Niels E Skakkebaek; Ewa Rajpert-De Meyts; Mathieu Laversanne; Tomislav Kuliš; Jason Gurney; Diana Sarfati; Katherine A McGlynn; Freddie Bray
Journal:  Int J Cancer       Date:  2019-12-28       Impact factor: 7.316

8.  The gender difference and mortality-to-incidence ratio relate to health care disparities in bladder cancer: National estimates from 33 countries.

Authors:  Shao-Chuan Wang; Wen-Wei Sung; Yu-Lin Kao; Tzuo-Yi Hsieh; Wen-Jung Chen; Sung-Lang Chen; Horng-Rong Chang
Journal:  Sci Rep       Date:  2017-06-28       Impact factor: 4.379

9.  Cancer Incidence in Europe: An Ecological Analysis of Nutritional and Other Environmental Factors.

Authors:  Pavel Grasgruber; Eduard Hrazdira; Martin Sebera; Tomas Kalina
Journal:  Front Oncol       Date:  2018-06-13       Impact factor: 6.244

10.  Favorable mortality-to-incidence ratios of kidney Cancer are associated with advanced health care systems.

Authors:  Wen-Wei Sung; Shao-Chuan Wang; Tzuo-Yi Hsieh; Cheng-Ju Ho; Cheng-Yu Huang; Yu-Lin Kao; Wen-Jung Chen; Sung-Lang Chen
Journal:  BMC Cancer       Date:  2018-08-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.